Cargando…
APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma
In this study, we analyzed the expression and clinical significance of apyrimidinic endodeoxyribonuclease 1 (APEX1) in hepatocellular carcinoma (HCC). The APEX1 mRNA and protein levels were significantly higher in HCC than adjacent normal liver tissues in multiple datasets from the Oncomine, GEO and...
Autores principales: | Cao, Lei, Cheng, Hongwei, Jiang, Qiuxia, Li, Hui, Wu, Zhixian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093175/ https://www.ncbi.nlm.nih.gov/pubmed/32167932 http://dx.doi.org/10.18632/aging.102913 |
Ejemplares similares
-
GDI2 is a novel diagnostic and prognostic biomarker in hepatocellular carcinoma
por: Zhang, Wen, et al.
Publicado: (2021) -
Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights
por: Yu, James, et al.
Publicado: (2023) -
Neuraminidase 1 (NEU1) promotes proliferation and migration as a diagnostic and prognostic biomarker of hepatocellular carcinoma
por: Hou, Guojun, et al.
Publicado: (2016) -
A novel seven-gene signature as Prognostic Biomarker in Hepatocellular Carcinoma
por: Xie, Hui, et al.
Publicado: (2020) -
Value of KPNA4 as a diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Xu, Mingxing, et al.
Publicado: (2021)